Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEMRITUX
2011-000221-68Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of rituximab in Glomerulonephritis (GN), sponsored by Assistance publique - Hôpitaux de Paris. Started May 2011; status: active.
02
Drugs
rituximab
03
Conditions
Glomerulonephritis (GN)
Beyond the preview
Go deeper on 2011-000221-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000221-68.